Arcadia Biosciences, Inc. (RKDA) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 154 transactions totaling $30.2M, demonstrating a bullish sentiment with $26.6M in net insider flow. The most recent transaction on Aug 1, 2024 involved a purchase of 700 shares valued at $1.4K.
No significant insider buying has been recorded for RKDA in the recent period.
No significant insider selling has been recorded for RKDA in the recent period.
Based on recent SEC filings, insider sentiment for RKDA is bullish with an Insider Alignment Score of 94/100 and a net flow of $26.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Arcadia Biosciences, Inc. (RKDA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading RKDA stock, having executed 154 transactions in the past 90 days. The most active insider is G. Sperling 2012 Irrevocable Trust No. 3. John (Executive), who has made 4 transactions totaling $8.0M.
Get notified when executives and directors at RKDA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | J. Schaefer Thomas | Executive | Purchase | 700 | $2.06 | $1.4K | |
| Aug 1, 2024 | Kawakami Mark | Executive | Purchase | 700 | $2.06 | $1.4K | |
| Feb 1, 2024 | J. Schaefer Thomas | Executive | Purchase | 700 | $2.06 | $1.4K | |
| Aug 4, 2023 | J. Schaefer Thomas | Executive | Purchase | 649 | $3.67 | $2.4K | |
| May 30, 2023 | Jacot Stanley Jr | Executive | Purchase | 5,000 | $4.31 | $21.6K | |
| Feb 1, 2023 | J. Schaefer Thomas | Executive | Purchase | 700 | $0.23 | $161 | |
| Aug 1, 2022 | Haley Pamela | Executive | Purchase | 700 | $0.70 | $490 | |
| Aug 3, 2020 | Haley Pamela | Executive | Purchase | 700 | $3.16 | $2.2K | |
| Aug 3, 2020 | Shultz Randall | Executive | Purchase | 700 | $3.16 | $2.2K | |
| Aug 3, 2020 | T. Plavan Matthew | Executive | Purchase | 585 | $3.16 | $1.8K | |
| Feb 3, 2020 | T. Plavan Matthew | Executive | Purchase | 700 | $1.72 | $1.2K | |
| Feb 3, 2020 | Reiter Sarah | Executive | Purchase | 700 | $1.72 | $1.2K | |
| Feb 3, 2020 | Haley Pamela | Executive | Purchase | 700 | $1.72 | $1.2K | |
| Dec 23, 2019 | Reiter Sarah | Executive | Purchase | 900 | $5.95 | $5.4K | |
| Nov 19, 2019 | Reiter Sarah | Executive | Purchase | 1,000 | $4.52 | $4.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 39 | $28.4M | 91.3% |
Sale(S) | 46 | $1.8M | 5.7% |
Exercise(M) | 48 | $867.9K | 2.8% |
Award(A) | 7 | $69.9K | 0.2% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 12 | $0 | 0.0% |
Insiders at Arcadia Biosciences, Inc. are accumulating shares at an accelerated pace. With 22 insiders making 154 transactions totaling $28.4M in purchases versus $1.8M in sales, the net buying activity of $26.6M signals strong executive confidence. G. Sperling 2012 Irrevocable Trust No. 3. John (Executive) leads the buying activity with $8.0M in transactions across all time.